Montreal, Canada · Founded 2008 · Privately Held (backing)
Developer of cold plasma delivery system designed to reduce cancer recurrence. NexPlasmaGen is based in Montreal, Canada and was founded in 2008. Its last reported valuation was $6.6 million in Dec 2024. It has raised $960,000.
Last reported valuation
$6.6M
Oct 2026
Priced at
—
Total raised
$960K
Last round
—
Cap table — not yet on record
NexPlasmaGen's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NexPlasmaGen with a free account
·The complete investor list: 25 names
·Watch NexPlasmaGen: the Monday email on marks, rounds and moves
